ArticleSignal transduction and targeted therapy2023

Discovery of IHMT-MST1-39 as a novel MST1 kinase inhibitor and AMPK activator for the treatment of diabetes mellitus.

Junjie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.